GöteborgBIO
Friday 3 September, 2010
Home
Vitrolife starts a company in Japan
Vitrolife establishes a market organization of its own in Japan to strengthen its position in this market, the next largest in the world with regard to the number of infertility treatments.
"The establishment of a company of our own, with an office in Tokyo, will markedly increase our opportunities to create closer and more effective contacts with our customers and thereby give them even better service, something which is crucial in the Japanese market," says Marcus Hedenskog, Head of the newly formed Vitrolife KK. Marcus has more than 15 years' experience of working in the Japanese market.

Demand for infertility treatments continues to be very high in Japan, not least due to the fact that people there are planning to have children later and later in life, which means an increased risk of infertility and a better financial capacity to pay for infertility treatments.
"With the investments in the building up of local sales organizations in China and now in Japan, we are getting closer to one of our strategic objectives, to build up a market organization that covers all important markets and we are significantly increasing our opportunities for even faster growth in Asia, "says Vitrolife's VP Marketing & Sales Nils Sellbom.

April 24, 2009
Gothenburg
Magnus Nilsson
CEO

 
Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 61.

Updated: 2010-08-25
Print this page
Print this page
GöteborgBIO | Address: Medicinaregatan 8a | SE-413 46 Göteborg | Sweden | Fax: +46 31-41 97 00